Sabag Mark — SEC insider filings
SEC reporting owner CIK 1721442. 31 insider filings on record with FilingPulse; latest filed 2026-11-12.
Transaction summary — filings shown
Covers all 31 filings on record, filed 2021-02-11 to 2026-11-12. Counts and totals are arithmetic on values as filed — descriptive data, not a recommendation.
- Open-market purchases (code P, non-derivative): none reported.
- Open-market sales (code S, non-derivative): 10 legs across 9 filings — 1,256,669 shares, $28,813,535 total (shares × price as filed).
- Other reported legs (grants, option exercises, tax withholding, gifts, derivative-security transactions, …): 79.
- Largest priced transaction: sale of 337,915 shares @ $18.04 ($6,097,304) in TEVA PHARMACEUTICAL INDUSTRIES LTD, filed 2025-05-12.
By issuer — same filings
Open-market purchase/sale legs on non-derivative securities, grouped by issuer. Role is as filed on the newest filing for that issuer. Dollar totals cover priced legs only (shares × price as filed). Ordered by priced transaction value, largest first.
| Issuer | Role (as filed) | Filings | Purchases (P) | Sales (S) | Other legs |
|---|---|---|---|---|---|
| TEVA PHARMACEUTICAL INDUSTRIES LTD (TEVA) | See "Remarks" | 31 | — | 10 legs · 1,256,669 sh · $28,813,535 | 79 |
Insider filings — Sabag Mark
| Filed | Form | Issuer | Reported transactions | Source |
|---|---|---|---|---|
| 2026-11-12 | 4 | TEVA PHARMACEUTICAL INDUSTRIES LTD (TEVA) | Option exercise (M): 44,710 @ $34.90 · Sale (S): 44,710 @ $44.14 · Option exercise (M): 44,710 (derivative) @ $0 | EDGAR |
| 2026-11-06 | 4 | TEVA PHARMACEUTICAL INDUSTRIES LTD (TEVA) | Option exercise (M): 46,000 @ $34.90 · Sale (S): 46,000 @ $41.93 · Option exercise (M): 46,000 (derivative) @ $0 | EDGAR |
| 2026-05-04 | 4 | TEVA PHARMACEUTICAL INDUSTRIES LTD (TEVA) | Sale (S): 144,180 @ $34.99 | EDGAR |
| 2026-03-19 | 4 | TEVA PHARMACEUTICAL INDUSTRIES LTD (TEVA) | Sale (S): 62,102 @ $30.14 | EDGAR |
| 2026-03-09 | 4 | TEVA PHARMACEUTICAL INDUSTRIES LTD (TEVA) | Option exercise (M): 15,723 · Option exercise (M): 15,723 (derivative) @ $0 | EDGAR |
| 2026-03-06 | 4 | TEVA PHARMACEUTICAL INDUSTRIES LTD (TEVA) | Option exercise (M): 33,512 · Option exercise (M): 18,601 · Option exercise (M): 33,512 (derivative) @ $0 · Option exercise (M): 18,601 (derivative) @ $0 · Grant/award (A): 30,385 (derivative) @ $0 | EDGAR |
| 2026-03-05 | 4 | TEVA PHARMACEUTICAL INDUSTRIES LTD (TEVA) | Option exercise (M): 24,900 · Option exercise (M): 141,478 · Option exercise (M): 24,900 (derivative) @ $0 · Option exercise (M): 141,478 (derivative) @ $0 | EDGAR |
| 2026-01-29 | 4 | TEVA PHARMACEUTICAL INDUSTRIES LTD (TEVA) | Grant/award (A): 141,478 (derivative) @ $0 | EDGAR |
| 2025-12-11 | 4 | TEVA PHARMACEUTICAL INDUSTRIES LTD (TEVA) | Option exercise (M): 118,724 @ $18.61 · Sale (S): 118,724 @ $28.75 · Sale (S): 98,168 @ $28.70 · Option exercise (M): 118,724 (derivative) @ $0 | EDGAR |
| 2025-05-12 | 4 | TEVA PHARMACEUTICAL INDUSTRIES LTD (TEVA) | Sale (S): 337,915 @ $18.04 | EDGAR |
| 2025-03-07 | 4 | TEVA PHARMACEUTICAL INDUSTRIES LTD (TEVA) | Option exercise (M): 23,765 · Option exercise (M): 23,765 (derivative) @ $0 · Grant/award (A): 62,893 (derivative) @ $0 | EDGAR |
| 2025-03-06 | 4 | TEVA PHARMACEUTICAL INDUSTRIES LTD (TEVA) | Option exercise (M): 33,512 · Option exercise (M): 18,601 · Option exercise (M): 183,169 · Option exercise (M): 33,512 (derivative) @ $0 · Option exercise (M): 18,601 (derivative) @ $0 · Option exercise (M): 183,169 (derivative) @ $0 | EDGAR |
| 2025-03-05 | 4 | TEVA PHARMACEUTICAL INDUSTRIES LTD (TEVA) | Option exercise (M): 24,900 · Option exercise (M): 24,900 (derivative) @ $0 | EDGAR |
| 2025-02-14 | 4 | TEVA PHARMACEUTICAL INDUSTRIES LTD (TEVA) | Sale (S): 177,626 @ $16.25 | EDGAR |
| 2025-01-30 | 4 | TEVA PHARMACEUTICAL INDUSTRIES LTD (TEVA) | Grant/award (A): 183,169 (derivative) @ $0 | EDGAR |
| 2024-03-07 | 4 | TEVA PHARMACEUTICAL INDUSTRIES LTD (TEVA) | Option exercise (M): 23,764 · Option exercise (M): 58,133 · Sale (S): 100,000 @ $13.52 · Option exercise (M): 23,764 (derivative) @ $0 · Option exercise (M): 58,133 (derivative) @ $0 | EDGAR |
| 2024-03-05 | 4 | TEVA PHARMACEUTICAL INDUSTRIES LTD (TEVA) | Option exercise (M): 24,900 · Option exercise (M): 33,512 · Option exercise (M): 24,900 (derivative) @ $0 · Option exercise (M): 33,512 (derivative) @ $0 · Grant/award (A): 74,404 (derivative) @ $0 | EDGAR |
| 2024-03-01 | 4 | TEVA PHARMACEUTICAL INDUSTRIES LTD (TEVA) | Option exercise (M): 20,599 · Option exercise (M): 20,599 (derivative) @ $0 | EDGAR |
| 2024-02-01 | 4 | TEVA PHARMACEUTICAL INDUSTRIES LTD (TEVA) | Grant/award (A): 58,133 (derivative) @ $0 | EDGAR |
| 2023-03-07 | 4 | TEVA PHARMACEUTICAL INDUSTRIES LTD (TEVA) | Option exercise (M): 33,512 · Option exercise (M): 15,921 · Option exercise (M): 23,764 · Grant/award (A): 99,601 (derivative) @ $0 · Option exercise (M): 15,921 (derivative) @ $0 · Option exercise (M): 33,512 (derivative) @ $0 · +1 more | EDGAR |
| 2023-03-02 | 4 | TEVA PHARMACEUTICAL INDUSTRIES LTD (TEVA) | Option exercise (M): 20,598 · Option exercise (M): 50,242 · Option exercise (M): 20,598 (derivative) @ $0 · Option exercise (M): 50,242 (derivative) @ $0 | EDGAR |
| 2023-02-09 | 4 | TEVA PHARMACEUTICAL INDUSTRIES LTD (TEVA) | Grant/award (A): 50,242 (derivative) @ $0 | EDGAR |
| 2022-03-08 | 4 | TEVA PHARMACEUTICAL INDUSTRIES LTD (TEVA) | Option exercise (M): 15,920 · Option exercise (M): 43,358 · Option exercise (M): 23,764 · Option exercise (M): 15,920 (derivative) @ $0 · Option exercise (M): 43,358 (derivative) @ $0 · Grant/award (A): 134,048 (derivative) @ $0 · +1 more | EDGAR |
| 2022-03-02 | 4 | TEVA PHARMACEUTICAL INDUSTRIES LTD (TEVA) | Option exercise (M): 20,598 · Option exercise (M): 20,598 (derivative) @ $0 | EDGAR |
| 2022-02-10 | 4 | TEVA PHARMACEUTICAL INDUSTRIES LTD (TEVA) | Option exercise (M): 15,523 · Option exercise (M): 15,523 (derivative) @ $0 · Grant/award (A): 43,358 (derivative) @ $0 | EDGAR |
| 2021-05-13 | 4 | TEVA PHARMACEUTICAL INDUSTRIES LTD (TEVA) | Option exercise (M): 37,884 · Option exercise (M): 37,884 (derivative) @ $0 | EDGAR |
| 2021-03-17 | 4 | TEVA PHARMACEUTICAL INDUSTRIES LTD (TEVA) | Sale (S): 127,244 @ $11.22 | EDGAR |
| 2021-03-08 | 4 | TEVA PHARMACEUTICAL INDUSTRIES LTD (TEVA) | Option exercise (M): 15,920 · Option exercise (M): 15,920 (derivative) @ $0 · Grant/award (A): 95,057 (derivative) @ $0 | EDGAR |
| 2021-03-02 | 4 | TEVA PHARMACEUTICAL INDUSTRIES LTD (TEVA) | Option exercise (M): 20,598 · Option exercise (M): 20,598 (derivative) @ $0 | EDGAR |
| 2021-02-17 | 4 | TEVA PHARMACEUTICAL INDUSTRIES LTD (TEVA) | Option exercise (M): 5,712 · Option exercise (M): 5,712 (derivative) @ $0 | EDGAR |
| 2021-02-11 | 4 | TEVA PHARMACEUTICAL INDUSTRIES LTD (TEVA) | Option exercise (M): 15,523 · Grant/award (A): 65,339 · Option exercise (M): 15,523 (derivative) @ $0 · Grant/award (A): 37,884 (derivative) @ $0 | EDGAR |
FilingPulse's Form 4 archive currently extends back to 2020-11-20 and is expanding backward through EDGAR history; Forms 3 and 5 are covered live-forward since 2026-09-23 (no 3/5 history). Earlier filings by this insider may not be indexed yet. Names and roles are shown as filed.
GET https://api.filingpulse.io/v1/insider-trades?owner_cik=1721442 returns every filing on this page — normalized, with footnotes and derivative legs — and webhooks push new filings to you in seconds. Get a free API key → · API docs